Revue medicale de Liege最新文献_第8页

[Acute migraine treatment : recommendations to optimize management]. [急性偏头痛治疗：优化管理的建议]。

Revue medicale de Liege Pub Date : 2026-04-01

Grégory Timmermans, Michel Vandenheede

引用次数: 0

[Informed decisions, optimized consent : navigating medical information in the era of medicine 2.0]. [知情决策，优化同意：医学2.0时代的医疗信息导航]。

Revue medicale de Liege Pub Date : 2026-04-01

Justine Gudelj, Anne-Sophie Wery, Jérôme Schoenmaeckers, Olivier Wery

引用次数: 0

[Clinical approach and medical decision-making]. [临床方法和医疗决策]。

Revue medicale de Liege Pub Date : 2026-04-01

Patrizio Lancellotti

引用次数: 0

[Esophagobronchial fistula]. [Esophagobronchial瘘管病]。

Revue medicale de Liege Pub Date : 2026-04-01

Pierre Rouffignon, Lyonel Herman, Frédéric Fievet

引用次数: 0

[Severe flecainide poisoning successfully treated with lipid emulsion]. 脂质乳剂治疗重度黄曲霉胺中毒成功。

Revue medicale de Liege Pub Date : 2026-04-01

Delphine Saive, Julien Berg, Olivier Appoloni

引用次数: 0

[A 10-year of temporary mechanical circulatory support at the University Hospital of Liège]. [在利维奇大学医院接受了10年的临时机械循环支持]。

Revue medicale de Liege Pub Date : 2026-03-01

Gauthier Jacob, Vincent Tchana-Sato, Paul Massion, Mathieu Lempereur, François Stifkens, Marc Gilbert Lagny, Philippe Amabili

{"title":"[A 10-year of temporary mechanical circulatory support at the University Hospital of Liège].","authors":"Gauthier Jacob, Vincent Tchana-Sato, Paul Massion, Mathieu Lempereur, François Stifkens, Marc Gilbert Lagny, Philippe Amabili","doi":"","DOIUrl":"","url":null,"abstract":"Cardiogenic shock is characterized by failure of the cardiac pump, requiring early recognition and prompt hemodynamic stabilization. The SCAI-SHOCK classification, which grades severity across five stages, facilitates standardized clinical communication and ensures population homogeneity in clinical trials. In cases of cardiogenic shock refractory to medical treatment, temporary mechanical circulatory support (MCS) is essential to maintain systemic blood flow and preserve end-organ function. This monocentric retrospective study analyzes ten years of experience with temporary MCS at the University Hospital (CHU) of Liège. Data are presented according to ischemic and non-ischemic etiologies. Outcomes of temporary MCS in cardiac arrest refractory to conventional cardiopulmonary resuscitation, as well as the use of monoventricular microaxial pumps, are also evaluated. Close multidisciplinary collaboration is crucial to address reversible causes, limit the duration of low cardiac output, and improve patient prognosis. This study highlights the evolution of management strategies and the importance of integrated care in optimizing clinical outcomes.","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"81 3","pages":"178-186"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147438643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Viral, fungal and parasitic dermato-zoonoses]. [病毒性、真菌性和寄生性皮肤-人畜共患病]。

Revue medicale de Liege Pub Date : 2026-03-01

Amandine Bouillenne, Gilles Absil, Bernard Mignon, Arjen Nikkels

引用次数: 0

[Autosomal dominant polycystic kidney disease]. [常染色体显性多囊肾病]。

Revue medicale de Liege Pub Date : 2026-03-01

Charlotte Leemans, Laura Massoz, Romain Gillard, Vinciane Dideberg, François Jouret

{"title":"[Autosomal dominant polycystic kidney disease].","authors":"Charlotte Leemans, Laura Massoz, Romain Gillard, Vinciane Dideberg, François Jouret","doi":"","DOIUrl":"","url":null,"abstract":"Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder. It is primarily caused by pathogenic variants in PKD1 and PKD2 genes. The natural history of ADPKD is characterized by progressive enlargement of the total kidney volume (TKV) due to continuous cyst development and expansion, ultimately resulting in a gradual decline of glomerular filtration rate (eGFR). ADPKD is a systemic disease that may involve hepatic cystic disease, intracranial aneurysms, and increased cardiovascular risk. The Mayo Imaging Classification, based on height-adjusted TKV and age, is the primary tool for identifying patients with rapidly progressive disease. It may be complemented by the PROPKD score (including the genetic diagnosis) and the longitudinal eGFR slope. These elements guide eligibility for disease-modifying therapy. Tolvaptan has demonstrated efficacy in slowing kidney enlargement and preserving eGFR in high-risk patients. Its use requires careful monitoring of liver enzymes and management of aquaretic side-effects. Comprehensive care includes strict blood pressure control, adequate hydration, dietary sodium restriction, cardiovascular risk reduction, and treatment of cyst-related complications. Extrarenal manifestations, particularly hepatic and neurological, require targeted screening in selected patients. Future perspectives focus on precision medicine, new biomarkers, innovative targeted therapies, and genomic approaches aiming to modify disease trajectory more effectively. This article provides an updated synthesis of the recently published KDIGO international recommendations for the management of ADPKD.","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"81 3","pages":"171-177"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147438713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Atlas of enhancement patterns in contrast-enhanced mammographyy]. [对比增强乳房x线摄影增强模式图谱]。

Revue medicale de Liege Pub Date : 2026-03-01

Dina Jleilati, Éric Lifrange, Denis Danthine

引用次数: 0

[Evolution of thoracic computed tomography after therapy with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis]. [囊性纤维化患者使用elexaftor、tezacaftor和ivacaftor治疗后胸部计算机断层扫描的进展]。

Revue medicale de Liege Pub Date : 2026-03-01

Matthieu Thimmesch, Christian Cheping Simo, Matthieu Boulay, Jessica Pirson, Alain Palem

{"title":"[Evolution of thoracic computed tomography after therapy with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis].","authors":"Matthieu Thimmesch, Christian Cheping Simo, Matthieu Boulay, Jessica Pirson, Alain Palem","doi":"","DOIUrl":"","url":null,"abstract":"Cystic fibrosis, the most common genetic disorder in Caucasian populations, is caused by mutations in the CFTR gene (Cystic Fibrosis Transmembrane Conductance Regulator), which disrupts chloride ion transport and leads to the production of viscous mucus, primarily affecting the lungs, digestive system, and liver. Traditional symptomatic treatment has been improved with the advent of CFTR modulators, notably the combination therapy of elexacaftor, tezacaftor, and ivacaftor (ETI), for patients carrying at least one F508del mutation. This retrospective study includes 23 patients treated with ETI, analyzing thoracic CT scan results before and after treatment using the Bhalla score. The results demonstrate a significant improvement in the Bhalla score (17.2 (± 3.8) before ETI vs 18.3 (± 3.4) after ETI, p < 0.001). The score improvement was observed in 78 % of patients, while 13 % remained stable, and 9 % showed deterioration. These results are consistent with other studies, although the effect on the improvement of bronchiectasis remains uncertain. Despite promising results, the study remains limited by its monocentric design and small sample size. Nevertheless, it confirms the beneficial effect of ETI on radiological pulmonary damage in CF patients.","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"81 3","pages":"144-149"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147438640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0